WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3901 Infant (under 12 months) mortality rate: 572
GDP / capita (US$): 9541 Child (under 5 years) mortality rate: 962

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 20'673  19'897  19'148  18'426  17'732  11'353  8'013  5'989 
Births 999  967  937  907  879  609  448  340 
Surviving infants 939  908  878  849  821  551  386  294 
Pop. less than 5 years 4'218  4'066  3'927  3'796  3'668  2'343  1'616  1'218 
Pop. less than 15 years 10'384  9'989  9'617  9'253  8'897  5'470  3'884  2'882 
Female 15-49 years 4'328  4'168  4'010  3'860  3'719  2'494  1'823  1'370 

Number of reported cases

(Click for retrospective incidence data for Niger (the))
Diphtheria
ChartChart
  73  12  102  34 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  776  7'693  1'142  1'224  272  21'319  20'463  36'811 
Mumps
ChartChart
 
Pertussis
ChartChart
  482  884  5'585  3'102  8'320 
Polio*
ChartChart
  33  32  311 
Rubella
ChartChart
  24  33  77 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  55  39 
Tetanus (total)**
ChartChart
  32  24  45  71  75  286  220  346 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Niger (the))
Vaccine year result method % card seen                                                
BCG 2012  85  EPI   70  99*  99  98  59  99*  35  82 
DTP1 2012  87  EPI   70  98  96  99*  98  99*  35 
DTP3 2012  78  EPI   70  92  90  93  92  96  25  35 
DTP4         
IPV1          85  27 
HepB_BD         
HepB3 2012  78  EPI   70  92  90  93  92  96 
Hib3 2012  78  EPI   70  92  90  93  92  96 
JapEnc         
MCV1          90  89  88  92  91  27  38 
MCV2          37  16 
MenA         
PCV1          96  88  43 
PCV2          89  79  24 
PCV3          89  74  13 
Pol3 2012  75  EPI   70  91  89  91  80  95  23  35 
Rota1          91  79  31 
RotaC          84  70  19 
RCV1         
TT2plus 2011  50  DHS/MICS   65  92  73  90  89  83  31  11 
PAB          38  37  21  21 
VAD1          49  43  43  50  58 
YFV 2012  73  EPI   70  85  89  87  88  90  10 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Niger (the))
BCG
  77  77  76  37  85  50  50 
DTP1
  87  85  89  87  87  46  46 
DTP3
  67  65  68  67  71  34  22 
HepB3
  67  65  68  67  71 
HepB_BD
 
Hib3
  67  65  68  67  71 
IPV1
  62  27 
MCV1
  74  73  72  76  75  37  25 
MCV2
  37  16 
PCV3
  64  49  13 
Pol3
  67  65  67  56  71  41  22 
RCV1
 
RotaC
  61  47  19 
YFV
  68  72  70  71  73  10 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 44  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 66
From 80 to 89% 23
From 50 to 79% 11
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9, 16 months; Yes
MenA 1 year; Yes From July 2017
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact, +4 weeks; +6 months; +1, +1 years; Yes 15-49 years
VitaminA 6, 12, 18, 23 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2011-2015  2011-2015  2011-2015  2011 - 2015  2011 - 2015 
Nº of districts with microplans that include activities to raise immunization coverage number 44  44  44  42  42  42  42 

System performance

Total Nº districts in country number 44  44  44  42  42  42  42 
Nº districts with DTP3 coverage >=80% number 39  33  38  38  41  38  38 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  75  86  90  98  90  90 
Nº districts with measles (MCV1) coverage >=95% number 14  12  12  19  18  22  11 
% of districts with MCV1 coverage >=95% From 0 to 100% 32  27  27  45  43  52  26 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 15  14        51  13 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes    No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.